StonvexLoading…
StonvexStonvexStonvexCore line items from CMBMF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $159.65M | $116.13M | $73.14M | $33.74M |
Operating Income | $-27.96M | $-22.01M | $-16.17M | $-9.60M |
Net Income | $-38.54M | $-29.67M | $-21.14M | $-12.02M |
EPS (Diluted) | $-1.34 | $-1.03 | $-0.74 | $-0.42 |
Total Assets | $137.14M | $147.32M | $148.72M | $159.29M |
Total Liabilities | $173.09M | $175.62M | $169.50M | $172.40M |
Cash & Equivalents | $11.33M | $9.73M | $15.79M | $27.81M |
Free Cash Flow OCF − CapEx | $-16.15M | $-18.88M | $-14.43M | $-5.04M |
Shares Outstanding | 28.94M | 28.72M | 28.72M | 28.69M |